Mepilex Border Sacrum clinically proven to reduce pressure ulcers in multiple studies
A C. Tod Brindle study, published in the World Council of Enterostomal Therapists Journal in 2010, demonstrates that Mepilex® Border Sacrum can reduce hospital-acquired pressure ulcers by reducing shear forces and optimizing microclimate, observing zero occurrence amongst a group of 43 high-risk ICU patients1.
The study has been tested and duplicated again and again, all over the world. What did other medical professionals find? Mepilex Border Sacrum works.
Use of a soft silicone, self-adherent, bordered foam dressing to reduce pressure ulcer formation in high risk patients
A randomized clinical trial by Peggy Kalowes, Melanie Li, Carole Carlson and Adele Sandusky.
The study included 367 patients. The 183 patients in the control group received standard of care, which resulted in seven pressure ulcers (one deep tissue injury (DTI), four in stage two, and two unstageable). The 184 patients in the intervention group received standard of care, plus Mepilex Border Sacrum, which resulted in one pressure ulcer (one DTI).
Results: The use of Mepilex Border Sacrum was found to be effective with statistical significance p=.001. Adoption of the wound dressing will improve outcomes in high risk patients.2
A prospective randomised control trial of the effectiveness of multi-layer silicone foam dressings in preventing pressure ulcers: the border trial
An investigation into the effectiveness of multi-layer soft silicone foam dressings in preventing intensive care unit pressure ulcers when applied in the emergency department to trauma and critically ill patients by Nick Santamaria, Marie Gerdtz, Sarah Sage, Jane McCann, Amy Freeman, Theresa Vassiliou, Stephanie De Vincentis, Ai Wei Ng, Elizabeth Manias, Wei Liu and Jonathan Knott.
The study included 313 patients. The 152 patients in the control group received standard of care, which resulted in 27 pressure ulcers. The 161 patients in the intervention group received standard of care, plus Mepilex Border Sacrum and Mepilex® Heel, which resulted in seven pressure ulcers.
Results: "Our findings have demonstrated a statistical and clinically significant benefit for the application of multi-layered soft silicone foam dressings for the prevention of sacral and heel pressure ulcers. When used in combination with thorough risk assessment and evidence-based pressure ulcer prevention strategies, the intervention resulted in a 10% reduction in pressure ulcer incidence[…] As a consequence of the findings of this study, our hospital has now mandated the use of these dressings for all patients who are at high risk of pressure ulceration."3
The pressure ulcer prevention care bundle: A collaborative approach to preventing hospital-acquired pressure ulcers in adult cardiac surgery patients
Study by Cecile Cherry and Paula Midyette.
Inclusion of Mepilex Border Sacrum in a care bundle used collaboratively by cardiac O.R. and CICU to reduce the incidence of post-operative pressure ulcers, especially deep tissue injuries.
Results: The implementation of a collaborative pressure ulcer prevention bundle reduced the incidence of hospital acquired pressure ulcers (HAPUs) and DTIs from 12.4 percent to ranging between 0 percent and 1.5 percent.4
Reduction of hospital acquired sacral pressure ulcers in the intensive care unit utilizing a soft silicone dressing
Study by Nancy Chaiken.
Enrolled a total of 273 patients in a six month study to determine if a soft silicone dressing could decrease the incidence of sacral HAPUs in the ICU.
Results: During the study, they were able to reduce the sacral HAPU rate in the ICU from 13.6 percent to 1.8 percent, representing an 86.8 percent reduction.5